iShares U.S. Pharmaceuticals ETF
Eli Lilly’s Breakthrough Weight Loss Drug Triumphs in Key Obesity Trial: What This Means for You
Eli Lilly has made exciting strides in the fight against obesity with its new drug, retatrutide. This medication just passed ... Read more
Eli Lilly’s Breakthrough Obesity Drug Retatrutide Triumphs in First Late-Stage Diabetes Trial: What It Means for You
Eli Lilly is making waves with its new obesity drug, retatrutide. Recently, it passed a critical late-stage trial focusing on ... Read more
Eli Lilly Unveils Innovative Zepbound: One Pen, One Month’s Supply – Revolutionizing Obesity Treatment!
Eli Lilly recently launched an exciting new version of its popular obesity drug, Zepbound. This new version comes in a ... Read more
Novo Nordisk Shares Drop 15% as Weight Loss Drug Fails to Compete with Eli Lilly’s Breakthrough in Latest Trial
Novo Nordisk’s stock dropped by 15% on Monday after news that its weight-loss drug, CagriSema, did not meet its main ... Read more
